3rd DCT, HYBRID & CENTRALISED CLINICAL TRIALS WORLD CONGRESS 2027 EUROPE
Where Innovation, Collaboration and Human‐Centred Design Meet to Transform Clinical Research
Millennium Hotel and Conference Centre Gloucester London, UK
Day 2 - Friday 26th February 2027
Implementation, Technology & Real‐World Delivery
- Lessons learned from real‐world decentralised and hybrid deployments across multiple therapeutic areas and geographies.
- Deviations and variability introduced by remote data sources, including device inconsistencies and patient behaviour.
- Site‐centric approaches to digital workflow integration that reduce burden and improve operational clarity.
- Strategies to ensure patient safety and data integrity in remote and hybrid trial environments.
Moderator:
Panellists:
- How AI can optimise protocol feasibility, reduce patient burden and improve operational predictability.
- Emerging digital biomarkers and remote assessment technologies that expand the scope of measurable endpoints.
- Predictive recruitment and retention models that support more accurate planning and resource allocation.
- Regulatory considerations for AI‐supported decision‐making and the validation of algorithmic outputs.
- How decentralisation enables faster early‐phase studies and more agile operational models for small teams.
- Digital recruitment strategies tailored to niche, rare and geographically dispersed patient populations.
- Cost‐efficiency gains achieved through remote procedures, simplified workflows and reduced site dependency.
- Partnership models that allow biotech organisations to leverage CRO and technology expertise effectively.
- Demonstrating real‐time dashboards that enhance operational oversight and support rapid decision‐making.
- Presenting strategies for harmonising data from remote and site‐based sources into a single, coherent ecosystem.
- Showcasing automated quality checks and deviation alerts that strengthen compliance and reduce manual review.
- Highlighting how integrated datasets support regulatory submissions and improve evidence completeness.
- Validated devices capable of producing clinical‐grade data suitable for regulatory acceptance.
- Patient adherence challenges and presenting usability strategies that improve long‐term engagement.
- How continuous monitoring can be integrated into trial workflows without overwhelming sites or patients?
- Evidence showing how remote monitoring enhances safety oversight and patient experience.
- Operational models that support multi‐country decentralised studies with consistent quality and oversight.
- Regulatory variability across regions and strategies for harmonising digital processes internationally.
- Technology harmonisation approaches that reduce fragmentation and improve operational efficiency.
- Lessons learned from large‐scale deployments across diverse therapeutic areas.
- Enterprise‐level strategies that embed digital trial capabilities into long‐term R&D planning.
- Frameworks for integrating decentralisation into clinical operations without disrupting existing workflows.
- Capability‐building initiatives that strengthen digital literacy and operational confidence across teams.
- Metrics used to measure digital transformation impact across portfolios.
- Approaches to ensure validity and reliability of digital endpoints collected through remote devices.
- Statistical methods for managing device variability and patient‐generated data inconsistencies.
- Hybrid methodologies that balance remote flexibility with scientific rigour.
- Recommendations for future standards that strengthen methodological consistency.
- Communication strategies that clearly explain digital trial expectations and reduce uncertainty.
- Support models that help patients navigate remote participation challenges with confidence.
- How co‐creation strengthens trust and improves the relevance of digital trial tools.
- Approaches to ensure equitable access to digital platforms across diverse populations.
- AI‐driven automation tools that reduce manual burden and streamline operational processes.
- Intelligent scheduling and remote visit optimisation features that improve trial efficiency.
- How workflow intelligence enhances predictability and reduces operational risk.
- Collaboration models that align technology innovation with sponsor and CRO needs.
- Combining insights from AI‐driven design, digital biomarkers and remote monitoring to shape next‐generation methodologies.
- Aligning biotech agility, CRO global scaling and pharma transformation to build unified operational models.
- Strengthening patient trust through transparent communication and inclusive digital engagement practices.
- Translating unified data platforms, automation and national policy into sustainable digital ecosystems.
Moderator:
Panelists:
Co-located with Patient Centricity & Collaboration World Congress 2027 Europe.
Joint Networking & Exhibit Area.
